eif4e1a Antibody

What are the key functions of eIF4E and eIF4A proteins in translation?

eIF4E functions as a cap-binding protein that recognizes and binds to the 7-methyl GTP cap structure of eukaryotic mRNAs, a critical first step in cap-dependent translation . This protein acts both in the cytoplasm to initiate and regulate protein synthesis and in the nucleus to facilitate export of specific mRNAs .

Meanwhile, eIF4A1 operates as an ATP-dependent RNA helicase and subunit of the eIF4F complex involved in cap recognition . According to current translation initiation models, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs, which is necessary to permit efficient binding of the small ribosomal subunit and subsequent scanning for the initiator codon . Both proteins ultimately promote cell proliferation and growth through their roles in translation regulation .

What applications are eIF4E and eIF4A antibodies commonly used for?

Research-grade antibodies against these translation factors are validated for multiple applications:

These antibodies are particularly useful for detecting protein expression levels, protein-protein interactions, subcellular localization, and analyzing translation complex formation in various experimental contexts .

What is the molecular weight of eIF4E protein that should be detected in Western blot analysis?

When performing Western blot analysis, researchers should expect to observe eIF4E at approximately 25 kDa . This has been confirmed in multiple studies, including validation experiments showing detection in parental cell lines but absence in knockout cell lines . The eIF4E protein is calculated to have a molecular weight of 25 kDa based on its amino acid sequence .

For eIF4A1, the expected molecular weight in Western blot analysis is 46 kDa, as consistently observed in experimental validations across multiple cell lines .

How does phosphorylation of eIF4E affect its function and experimental detection?

Phosphorylation of eIF4E, particularly on serine 209, significantly impacts its functionality by regulating the protein's affinity for the 7-methyl GTP cap structure and/or RNA . This post-translational modification also enhances the interaction between eIF4E and eIF4G, which together form the eIF4F complex essential for translation initiation .

From an experimental perspective, researchers should be aware that phosphorylation status can affect antibody binding efficiency depending on the epitope recognized by the antibody. When studying eIF4E phosphorylation, it's advisable to use antibodies specifically designed to detect either total eIF4E or phosphorylated forms, as appropriate for the research question . The correlation between eIF4E phosphorylation and increased translational rates in numerous cell types makes this an important parameter to monitor in translation regulation studies .

What is the significance of the mTORC1/4E-BP/eIF4E axis in immunological research?

The mTORC1/4E-BP/eIF4E signaling axis plays a crucial role in antibody class switching during adaptive immune responses . Research has demonstrated that disruption of this pathway can impair class switching through specific molecular mechanisms:

• mTORC1 inhibition with rapamycin suppresses class switching while preserving B cell proliferation

• Genetic or pharmacological disruption of eIF4E binding to eIF4G reduces cap-dependent translation

• This reduction specifically affects the expression of activation-induced cytidine deaminase protein without altering Aicda mRNA levels

• The translational impairment decreases antibody class switching independently of proliferation effects

These findings reveal that the eIF4E-mediated cap-dependent translation mechanism is specifically required for activation-induced cytidine deaminase protein expression, highlighting a potential target for immunomodulatory interventions .

How can researchers distinguish between closely related eIF4E family members in experimental systems?

Distinguishing between closely related eIF4E family members (including potential variants like eIF4E1a) requires careful antibody selection and experimental design. Consider these approaches:

• Select antibodies raised against unique epitopes that differ between family members

• Validate specificity using knockout or knockdown cell lines where one family member is absent

• Perform parallel western blots with multiple antibodies targeting different regions of the proteins

• Include positive and negative controls in each experiment

Evidence of antibody specificity can be seen in validation studies like those performed with eIF4E antibodies, where the antibody detects a specific band at approximately 25 kDa in parental cell lines but shows no detection in knockout cell lines , confirming true target recognition rather than cross-reactivity.

What are the optimal conditions for Western blot detection of eIF4E and eIF4A proteins?

For optimal Western blot detection of these translation factors, consider the following validated protocols:

For eIF4A1 detection:

• Antibody concentration: 1 μg/mL

• Sample loading: 10-20 μg of cell lysate per lane

• Validated cell lines: HeLa, Jurkat, Raw264.7, PC12, NIH 3T3

• Expected band size: 46 kDa

• Detection system: HRP-conjugated secondary antibody at 1/1000-1/1500 dilution

For eIF4E detection:

• Antibody dilution range: 1:100-1:5000 for Western blot

• Expected band size: 25 kDa

• Running conditions: Reducing conditions using standard immunoblot buffers

• Controls: Include GAPDH detection as loading control

• Validation: Use knockout cell lines when possible to confirm specificity

What immunoprecipitation (IP) protocols are most effective for studying eIF4E/eIF4A interactions with binding partners?

For successful immunoprecipitation of translation initiation factors and their binding partners:

• Start with 293 cell lysate or equivalent mammalian cell system

• Use antibody at appropriate dilution (1/50 dilution for the eIF4A1 antibody has been validated)

• For detection of immunoprecipitated complexes, use HRP-conjugated anti-rabbit IgG at approximately 1/1500 dilution

• Include negative controls (IP with non-specific IgG or PBS) to confirm specificity

• When investigating protein-protein interactions, consider cross-linking approaches to stabilize transient interactions

• For cap-binding protein complexes like those involving eIF4E, consider cap-analog pulldown assays as a complementary approach

What considerations should researchers make when performing immunofluorescence with eIF4E antibodies?

When conducting immunofluorescence studies with eIF4E antibodies:

• Cell fixation: Immersion fixation has been validated for detection in cell lines like MCF-7

• Antibody concentration: 10 μg/mL has been successfully used in published protocols

• Incubation time: 3 hours at room temperature is an effective protocol

• Detection system: Fluorophore-conjugated secondary antibodies (e.g., NorthernLights 557-conjugated Anti-Mouse IgG)

• Counterstaining: Nuclear counterstaining with DAPI provides context for localization

• Controls: Include both positive control cell lines and negative controls (secondary antibody only)

Remember that eIF4E has both nuclear and cytoplasmic functions, so distribution patterns may vary depending on cell type and conditions .

How can researchers resolve inconsistent Western blot results when detecting eIF4E or eIF4A?

When facing inconsistent Western blot results with these antibodies, consider these common issues and solutions:

• Multiple bands or unexpected molecular weights:

  • Ensure complete denaturation of samples (adequate heating in sample buffer)

  • Check for post-translational modifications affecting migration (phosphorylation changes MW)

  • Verify antibody specificity using knockout controls as demonstrated in published validations

  • Consider reducing or non-reducing conditions as appropriate for the epitope

• Weak or absent signals:

  • Optimize antibody concentration (1:100-1:5000 range for eIF4E antibodies)

  • Increase protein loading (20 μg of whole cell lysate has been validated)

  • Extend primary antibody incubation time or temperature

  • Verify protein expression in your specific cell type

• High background:

  • Increase blocking time or blocking agent concentration

  • Reduce primary and secondary antibody concentrations

  • Use more stringent washing protocols between steps

What controls should be included when studying mTORC1-dependent regulation of eIF4E function?

When investigating mTORC1-dependent regulation of eIF4E:

• Positive control: Include samples treated with known mTORC1 activators (e.g., insulin, amino acids)

• Negative control: Include samples treated with rapamycin, a specific mTORC1 inhibitor

• Pathway validation: Monitor phosphorylation status of other mTORC1 substrates (S6K1, 4E-BP1)

• Functional readout: Measure cap-dependent translation using reporter assays

• Specificity control: Compare effects on cap-dependent vs. cap-independent translation

• Genetic validation: Consider using cells with genetic manipulation of pathway components (mTOR, Raptor, 4E-BP knockouts/knockdowns)

Research has demonstrated that the mTORC1/4E-BP/eIF4E axis specifically affects expression of certain proteins like activation-induced cytidine deaminase without altering corresponding mRNA levels , making both protein and mRNA measurements important controls.

How should researchers interpret differences in eIF4E localization patterns across different cell types?

When analyzing eIF4E localization patterns:

• Expected pattern: eIF4E functions in both nuclear and cytoplasmic compartments

• Nuclear function: Required for export of specific mRNAs from nucleus to cytoplasm

• Cytoplasmic function: Initiates and regulates protein synthesis

• Cell-type variations: Different cell types may show varying distribution patterns based on their translational demands and nuclear export requirements

• Cell cycle effects: Consider whether cell cycle phase influences localization

• Stress response: Translation factor localization can change during stress conditions (oxidative stress, heat shock, nutrient deprivation)

To properly interpret differences, researchers should:

• Compare multiple cell types under identical experimental conditions

• Use nuclear and cytoplasmic markers for co-localization studies

• Consider quantitative analysis of nuclear/cytoplasmic ratios

• Correlate localization patterns with functional data (translation rates, mRNA export)